Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $920,170 - $1.08 Million
-9,500 Reduced 28.06%
24,362 $2.47 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $266,168 - $312,256
-2,800 Reduced 7.64%
33,862 $3.72 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $234,760 - $283,751
2,300 Added 6.69%
36,662 $3.98 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $456,080 - $556,160
4,000 Added 13.17%
34,362 $4.07 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $219,507 - $268,774
-1,900 Reduced 5.89%
30,362 $4.27 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $933,280 - $1.03 Million
8,000 Added 32.97%
32,262 $3.81 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $1.83 Million - $2.16 Million
-17,316 Reduced 41.65%
24,262 $2.81 Million
Q1 2021

May 19, 2021

BUY
$108.84 - $128.23 $2.06 Million - $2.43 Million
18,950 Added 83.75%
41,578 $4.98 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $734,685 - $800,596
6,997 Added 44.76%
22,628 $2.48 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $293,248 - $356,128
3,200 Added 25.74%
15,631 $1.7 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $96,478 - $123,480
1,260 Added 11.28%
12,431 $1.14 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $98,941 - $144,679
1,575 Added 16.41%
11,171 $882,000
Q4 2019

Feb 18, 2020

BUY
$78.51 - $87.4 $204,126 - $227,240
2,600 Added 37.16%
9,596 $834,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $32,736 - $35,496
400 Added 6.06%
6,996 $585,000
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $58,304 - $68,000
800 Added 13.8%
6,596 $555,000
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $117,408 - $141,946
1,773 Added 44.07%
5,796 $463,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $263,747 - $298,788
4,023 New
4,023 $291,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.